<DOC>
	<DOCNO>NCT02466191</DOCNO>
	<brief_summary>Pendular nystagmus corresponds endure fro eye oscillation without reset quick phase . The common cause acquire pendular nystagmus ( APN ) multiple sclerosis ( MS ) focal brainstem lesion ( oculopalatal tremor , OPT ) . Based pathophysiological hypothesis , pharmacological treatment acquire nystagmus thoroughly propose different publication case , series , review expert opinion . Acquired pendular nystagmus underwent rigorous treatment trial , lead proposal gabapentin memantine valuable drug . Whether gabapentin memantine effective APN associate OPT remain unclear , since none previous study evaluate effect medication group OPT patient . However , important issue prospect clinical use medication . In current study , investigator aim evaluate effect gabapentin memantine mean velocity , amplitude frequency pendular nystagmus , well visual acuity vision-specific health-related quality life score , group OPT patient</brief_summary>
	<brief_title>Treatment Pendular Nystagmus OPT</brief_title>
	<detailed_description />
	<mesh_term>Tremor</mesh_term>
	<mesh_term>Nystagmus , Pathologic</mesh_term>
	<mesh_term>Memantine</mesh_term>
	<mesh_term>Gabapentin</mesh_term>
	<mesh_term>gamma-Aminobutyric Acid</mesh_term>
	<criteria>Patients diagnosis oculopalatal tremor ( OPT ) , follow focal brainstem lesion . All patient may present chronic acquire pendular nystagmus due OPT , observe period 6 month . All patient inform design purpose study , give inform , write consent protocol , may approve local ethic committee . Age : 18 Able understand instruction Having health coverage Able sit 1 hour Stable dosage previous medication ( begin 3 week previously terminate end trial duration ) , except gabapentin memantine . For woman : efficient contraception experimental time two month follow treatment withdrawal . Ophthalmological Other ophthalmological disorder could impair correct visual acuity ( Maculopathy , Retinopathyâ€¦ ) Neurological Ongoing seizure Severe handicap allow sit position 1 hour Suicidal behavior risk Treatment Under memantine gabapentin medication ( medication stop least 1 week gabapentin 3 week memantine ) Under morphine , NmethylDaspartate amantadine , ketamine dextromethorphan Steroid medication current relapse ( begin 3 week previously terminate end trial duration Known hypersensitivity memantine gabapentin General Unstable medical state Patient galactose intolerance , lapp lactase deficiency glucosegalactose malabsorption Moderate renal failure ( creatinine clearance &lt; 50 mL/min bioassay date less one month ) Recent heart infarction ( &lt; 3months ) Unstable congestive heart insufficiency Unstable arterial hypertension Leucopenia ( &lt; 2500/mm3 ) Transaminase increase ( &gt; 5 time normal value ) Pregnancy ( question ) Tutelage legal protection measure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>nystagmus</keyword>
	<keyword>pharmacological trial</keyword>
	<keyword>multiple sclerosis</keyword>
	<keyword>oscillopsia</keyword>
</DOC>